Abstract
Bottromycin is an antibiotic against methicillin-resistant staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE). It has a novel mode of action: it inhibits bacterial protein synthesis by blocking the binding of aminoacyl-tRNA to the A site on the 50S ribosome. No cross resistance to existing drugs has been observed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have